Description
Tratamiento y prevención del broncoespasmo asociado con asma y enfermedad pulmonar obstructiva crónica (EPOC)
Conservar a temperatura ambiente (15°C a 25°C)
TYSABRI® es un medicamento biológico de administración intravenosa que contiene Natalizumab
Novartis Pharma
Principio activo: Nimodipino
ACIDO RISEDRONICO 4 GRAG 35 MG GLUCOSA 10.00 G Tratamiento y prevención del broncoespasmoCaja C 4 Grageas
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
